Daewoong's botulinum toxin Nabota enters Kuwait

Daewoong Pharmaceutical's botulinum toxin brand Nabota has entered Kuwait, expanding its presence to seven Middle Eastern markets while setting a record among Korean botulinum toxin makers in the region. According to Daewoong Pharmaceutical on Thursday, it began supplying Nabota to Kuwait earlier this month on top of its existing market lineup of Saudi Arabia, the United Arab Emirates, Turkiye, Qatar, Egypt and Bahrain in the Middle East. With the latest expansion, Daewoong underscored that Nabo